Investors
Biodexa Pharmaceuticals PLC (dual listed on LSE AIM: BDRX; and NASDAQ: BDRX) is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines.
Takeover Panel Waiver
Documents relating to the proposed waiver of obligations under Rule 9 of the City Code on Takeovers and Mergers can be found below.
A&B HK Articles of Association
A&B Lock-in Agreement 29 January 2019
A&B Subscription Letter 29 January 2019
CMS Annual Report 2016
CMS Annual Report 2017
CMS Articles of Association
CMS Interim Report 30 June 2018
CMS Licence Agreement
CMS Venture Lock-in Agreement 29 January 2019
CMS Venture Subscription Letter 29 January 2019
Irrevocable Undertaking Craig Cook
Irrevocable Undertaking John Johnston
Irrevocable Undertaking Michele Luzi
Irrevocable Undertaking Nick Robbins-Cherry
Irrevocable Undertaking Pavlo Protopapa
Irrevocable Undertaking Rolf Stahel
Irrevocable Undertaking Sijmen de Vries
Irrevocable Undertaking Simon Turton
Midatech US Acquisition Agreement
Panmure Consent Letter
Placing Agreement 4 February 2019
Relationship Agreement 29 January 2019
Stifel Consent Letter
Warrant Instrument 29 January 2019